Loading ...
vitaminscan causeharm in patients with chronic kidney disease
| 10.1016 / j.urolonc.2020.02.017 | DeepDyve Acroleincontributesto urothelial carcinomas in patients with chronic kidney disease
Renagel Renagel ... that is usedto preventhypocalcaemia in patients with chronic kidney disease
Inflammation remains as a nontraditional but critical risk factorto causeCVD in patients with chronic kidney disease
Factorsinfluencehospitalisations in patients with chronic kidney disease
Physicians ... vitamin D metabolismmay leadto symptomatic hypocalcemia in patients with chronic kidney disease
an under - recognized and underdiagnosed etiologycontributingto hyperkalemia in patients with chronic kidney disease
to introduce novel non - invasive endovascular approachto createfistulas ( EndoAVF ) in patients with chronic kidney disease
gadolinium - based MR agentscan causeNSF in patients with chronic kidney disease
to worse outcomes after percutaneous coronary intervention ( PCIcontributesto worse outcomes after percutaneous coronary intervention ( PCI
to secondary hyperparathyroidism and renal osteodystrophyleadsto secondary hyperparathyroidism and renal osteodystrophy
to a reduced rate of progression to dialysis 1 year after the catheter procedure [ 24can leadto a reduced rate of progression to dialysis 1 year after the catheter procedure [ 24
to secondary hyperparathyroidism , soft tissue calcificationcontributesto secondary hyperparathyroidism , soft tissue calcification
➣ Anemia(passive) caused by➣ Anemia
disability(passive) caused bydisability
heart , kidney and blood vessel damagecan causeheart , kidney and blood vessel damage
the occurrence of complications and poor outcomesinfluencethe occurrence of complications and poor outcomes
to13 Mar Clinical guideline [ CGleadsto13 Mar Clinical guideline [ CG
to the development of heart disease and deathleadingto the development of heart disease and death